Skip to main content

Roche Pharma Switzerland

The Roche Pharma division of Switzerland aims to realise holistic solutions in various areas of treatment, including prevention, diagnosis, and therapy as well as patient care.

Who we are

Roche Pharma (Switzerland) Ltd is the Swiss national subsidiary of Roche and its approximately 160 employees are responsible for ensuring that patients in Switzerland have access to Roche's innovative portfolio of medicines. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology, ophthalmology and rare diseases.

More about Roche Pharma Switzerland
Pharma Switzerland

Our pharmaceuticals

Roche has brought many highly effective medicines to market. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology and rare diseases.

Read more
Pharma Switzerland

From molecule to medicine

Roche utilises cutting-edge technologies to create numerous new chemical compounds in the laboratory by combining known elements.

Read more
Pharma Switzerland

For patients and medical professionals

Living with an illness is a challenge for patients and those affected and raises many questions.

Read more
Pharma Switzerland

Patient Safety

All medicines can have adverse effects in addition to their benefits, such as headaches or nausea - known as side effects.

Read more

Discover more

  • About Roche Switzerland

    What began in Basel 130 years ago with a visionary idea is now one of the leading companies. With over 15,000 employees, Switzerland is and remains a key success factor for Roche.

  • Our sites

    Roche sites in Switzerland offer attractive jobs in science and research, administration and sales, production and logistics and much more.

  • Adverse drug reaction

    Report an adverse drug reaction

  • Potential product complaint

    If you have a potential product complaint, please report it